{
    "nctId": "NCT04330716",
    "briefTitle": "Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers",
    "officialTitle": "Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers - GeneBOPP",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Metastatic Prostate Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 269,
    "primaryOutcomeMeasure": "Rate of patients who have germline genetic tests",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Potentially eligible participants will be identified via medical record screening and/or in accordance with their clinical visit. A HIPAA waiver of authorization will be obtained by the enrolling Institution as needed to have access to the subject's medical record information for screening of eligibility.\n* A member of the study team will approach the potentially eligible participant in clinic and discuss the trial. Potentially eligible participants may choose to discuss participation further with their physician at their appointment\n* Age \u2265 18 years\n* Breast, ovarian, pancreatic, or metastatic prostate cancer\n* No prior cancer genetic testing\n* Ability to understand and the willingness to sign an informed consent document\n\nExclusion Criteria:\n\n* Pregnant\n* Prisoners\n* Inability to understand English as a spoken language in a healthcare context\n* Known hematologic malignancy (e.g. CLL)",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}